US Lead (Director), Global Regulatory Policy & Innovation
Takeda Pharmaceuticals
Olivia Ziolkowski is an attorney with 17+ years of FDA-focused professional experience. She currently serves as US Lead (Director) in Takeda’s Global Regulatory Policy & Innovation team leading development and innovation in US regulatory policy. Prior to joining Takeda, Olivia provided strategic regulatory counsel in the US pharma/biotech space, including 8 years in private consulting and 7 years in FDA's Office of Regulatory Policy in the Center for Drug Evaluation & Research and most recently, 4+ years identifying and advising around regulatory policy challenges in gene therapy, with an emphasis in AAV gene therapies.
Disclosure information not submitted.
Navigating the Unique Complexities of CMC Challenges for Cell Therapies
Thursday, October 5, 2023
3:30 PM – 4:30 PM EDT